Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Breast Cancer (Tokyo, Japan)|May 10, 2012
Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in JapanShozo Ohsumi, Kojiro Shimozuma
Breast Cancer (Tokyo, Japan)|January 14, 2004
Techniques for the neurological examination of taxane-induced neuropathyShozo Ohsumi, Yoshihide Sunada
Japanese Journal of Clinical Oncology|May 28, 2014
Factors affecting enrollment in a randomized controlled trial for Japanese metastatic breast cancer patients (SELECT BC-FEEL)--a prospective studyShozo Ohsumi, Hirofumi Mukai, Yasuo Ohashi
Breast Cancer Research and Treatment|September 11, 2002
Prognostic value of thermographical findings in patients with primary breast cancerShozo Ohsumi, Shigemitsu Takashima, Kenjiro Aogi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2002
Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer CenterShozo Ohsumi, Shigemitsu Takashima, Toshiaki Saeki, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Current status of health outcome assessment of medical treatment in breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Shozo Ohsumi, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancersRieko Nishimura, Toshiaki Saeki, Shozo Ohsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Retrospective evaluation of the safety of pamidronate administration at the dose of 90 mg/day/month in Japanese breast cancer patients with bone metastasis]Kenjiro Aogi, Atsushi Okita, Naruto Taira, et al.
Hiroshima Journal of Medical Sciences|April 26, 2005
Progressive central nervous system metastases in responder patients for outside central nervous system metastases on trastuzumab-based therapy--report of two cases of refractory breast cancerRiki Okita, Toshiaki Saeki, Shigemitsu Takashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2005
[Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer]Yasuhiro Tsutani, Toshiaki Saeki, Kenjiro Aogi, et al.
Pageof 13